Product References

Isolation of Borrelia miyamotoi and Other Borreliae Using a Modified BSK Medium

Posted by Adam Awdish on

Isolation of Borrelia miyamotoi and Other Borreliae Using a Modified BSK Medium

Innovative Grade US Origin Mouse Balb C Serum from Innovative Research was used in the following study:   Isolation of Borrelia miyamotoi and Other Borreliae Using a Modified BSK Medium Adam J. Replogle, Christopher Sexton, John Young, Luke C. Kingry, Martin E. Schriefer, Marc Dolan, Tammi L. Johnson, Neeta P. Connally, Kerry A. Padgett & Jeannine M. Petersen Scientific Reports January 21, 2021 When looking for proof of bacterial infection in a patient, primary culture recovery is the most common procedure to confirm an infection. Despite the rise in the number of infections over the last decade and the identification of...

Read more →

BMI1 Enables Extensive Expansion of Functional Erythroblasts from Human Peripheral Blood Mononuclear Cells

Posted by Adam Awdish on

BMI1 Enables Extensive Expansion of Functional Erythroblasts from Human Peripheral Blood Mononuclear Cells

Pooled Human Plasma (Blood Derived) from Innovative Research was used in the following study:   BMI1 Enables Extensive Expansion of Functional Erythroblasts from Human Peripheral Blood Mononuclear Cells Senquan Liu, Mengyao Wu, Moira Lancelot, Jiusheng Deng, Yongxing Gao, John D. Roback, Tong Chen, and Linzhao Cheng Molecular Therapy May 5, 2021 One of the most common treatments for patients with anemia or suffering from major blood loss is a red blood cell (RBC) transfusion from an ABO-matched donor. However, the number of cases that require these transfusions is increasing yearly, creating a growing need for blood donations amid blood shortages...

Read more →

Photooxidation-Induced Fluorescence Amplification System for an Ultra-Sensitive Enzyme-Linked Immunosorbent Assay (ELISA)

Posted by Adam Awdish on

Photooxidation-Induced Fluorescence Amplification System for an Ultra-Sensitive Enzyme-Linked Immunosorbent Assay (ELISA)

Pooled Human Plasma Apheresis Derived from Innovative Research was used in the following study:   Photooxidation-Induced Fluorescence Amplification System for an Ultra-Sensitive Enzyme-Linked Immunosorbent Assay (ELISA) Youhee Heo, Kwanwoo Shin, Min Cheol Park, and Ji Yoon Kang Scientific Reports March 12, 2021 It’s important to be able to detect biomarkers, such as proteins or nucleic acids, at very low concentrations in various bodily fluids when attempting to diagnose diseases. There has been a lot of contemporary research looking to identify other disease biomarkers, particularly ones detectable in blood, and reliable methods for detecting said biomarkers with low cost and high...

Read more →

An Effective and Safe Enkephalin Analog for Antinociception

Posted by Adam Awdish on

An Effective and Safe Enkephalin Analog for Antinociception

Innovative Grade US Origin Mouse C57BL6 Plasma from Innovative Research was used in the following study:   An Effective and Safe Enkephalin Analog for Antinociception K. K. DurgaRao Viswanadham, Roland Böttger, Lukas Hohenwarter, Anne Nguyen, Elham Rouhollahi, Alexander Smith, Yi-Hsuan Tsai, Yuan-Yu Chang, Christopher Llynard Ortiz, Lee-Wei Yang, Liliana Jimenez, Siyuan Li, Chan Hur, and Shyh-Dar Li Pharmaceutics June 22, 2021 Many injuries and diseases may lead to patients experiencing acute pain as a symptom, and a majority of surgery and trauma patients experience severe or intolerable pain that has the potential to result in chronic pain. Chronic pain is...

Read more →

Two Distinct Genotypes of KPC-2-Producing Klebsiella pneumoniae Isolates from South Korea

Posted by Adam Awdish on

Two Distinct Genotypes of KPC-2-Producing Klebsiella pneumoniae Isolates from South Korea

Pooled Human Serum Off The Clot from Innovative Research was used in the following study:   Two Distinct Genotypes of KPC-2-Producing Klebsiella pneumoniae Isolates from South Korea Jee Hong Kim, Yun Young Cho, Ji Young Choi, Yu Mi Wi, and Kwan Soo Ko Antibiotics July 26, 2021 In South Korea in 2010, the emergence of carbapenemase-producing Gram-negative bacteria caused serious therapeutic concern and challenges. In particular, Klebsiella pneumoniae, which produces K. pneumoniae carbapenemase (KPC), has proven to be one of the most threatening of these carbapenem resistance determinants in clinical settings. This is because K. pneumoniae is difficult to control...

Read more →


×